Article
Pharmacoresistant seizures and IDH mutation in low-grade gliomas
1 Jan 2021
Abstract excerpt
Abstract Background Many low-grade gliomas (LGG) harbor isocitrate dehydrogenase (IDH) mutations. Although IDH mutation is known to be epileptogenic, the rate of refractory seizures in LGG with IDH mutation vs wild-type had not been previously compared. We therefore compared seizure pharmacoresistance in IDH-mutated and wild-type LGGs. Methods Single-institution retrospective study of patients with histologic...
Topics
Join the communities discussing this publication.